Quantcast

Latest cell therapy Stories

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-12 08:33:04

SAN DIEGO, May 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced that the Company's Excellagen(®) flowable dermal matrix in combination with Orbsen Therapeutics' mesenchymal stromal stem cell therapy Cyndacel-M(TM) has been selected for clinical evaluation in a Phase 1b safety study for the potential treatment of chronic diabetic wounds to be funded by the European Union under EU Framework 7 (FP7). The project, known by the...

2014-05-12 08:32:37

DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sqctb8/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The...

2014-05-08 23:12:18

Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute are granted U.S. Patent No. 8,716,017 entitled, “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells.” San Diego, CA (PRWEB) May 08, 2014 Xcelthera Inc, a major innovator in the stem cell research market and one of the first U.S. companies formed for clinical applications of human embryonic stem cell (human ES cell)...

2014-05-08 12:29:52

SALT LAKE CITY, May 8, 2014 /PRNewswire-USNewswire/ -- Mice severely disabled by a multiple sclerosis (MS) - like condition could walk less than two weeks following treatment with human stem cells. The finding, which uncovers new avenues for treating MS, will be published online on May 15, 2014, in the journal Stem Cell Reports. http://photos.prnewswire.com/prnvar/20140205/DC59634LOGO When scientists transplanted human stem cells into MS mice, they predicted the cells would be...

2014-05-06 16:31:58

NEW YORK, May 6, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon and founder of Blue Horizon International, was awarded a temporary license to practice medicine in Nigeria. Dr. Mehling, a researcher and philanthropist, is spearheading groundbreaking research in stem cell therapy focused on the health benefits of cell therapy in treating and managing diseases.Blue Horizon International is a healthcare consulting company with a unique concept that...

2014-05-02 23:04:19

The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html (PRWEB) May 02, 2014 The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis &...

Stem Cells Of Infertile Men Used To Create Preliminary Sperm Cells
2014-05-02 08:25:30

April Flowers for redOrbit.com - Your Universe Online A new study, from the Stanford University School of Medicine and Montana State University, demonstrates that, when implanted into the reproductive system of a mouse model, stem cells created from adult, infertile men will yield primordial germ cells. Primordial germ cells normally become sperm cells. The findings, published in Cell Reports, help to further our understanding of a genetic cause of male infertility and basic sperm...

2014-05-01 23:07:16

The Cell Analysis Market is broadly classified based on products, applications, end users, and geographies. The cell analysis market is expected to witness a reasonable growth in the forecast period - http://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html. (PRWEB) May 01, 2014 The “Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, Qpcr), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology,...

2014-05-01 23:05:49

Juvenile Diabetes Cure Alliance report analyzes cure research projects that have the potential to change the lives of people with type 1. New York, NY (PRWEB) May 01, 2014 Of the 382 active type 1 diabetes clinical trials, only eight have the potential to deliver a near-term cure, according to a new report from the Juvenile Diabetes Cure Alliance. Assuming all trails are successful and the project received uninterrupted funding, the earliest a potential cure could be on the market is...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'